Lumiracoxib

Contraindicated

Lumiracoxib Ketorolac Acular Enhanced gastrointestinal adverse effects (peptic ulcers, gastrointestinal bleeding and/or perforation) Details Lumiracoxib Ketorolac Injection Acular Enhanced gastrointestinal adverse effects (peptic ulcers, gastrointestinal bleeding and/or perforation) Details Lumiracoxib Ketorolac Nasal Spray Sprix Enhanced gastrointestinal adverse effects (peptic ulcers, gastrointestinal bleeding and/or perforation) Details Lumiracoxib Ketorolac Ophthalmic Acular Enhanced gastrointestinal adverse effects (peptic ulcers, gastrointestinal bleeding and/or perforation) Details

Major

Lumiracoxib Amitriptyline Elavil Explained An increased risk of bleeding Details Lumiracoxib Sertraline Explained An increased risk of bleeding Details Lumiracoxib Apixaban Eliquis Explained An increased risk of bleeding Details Lumiracoxib Aspirin Acuprin® An increased risk of bleeding, decreased renal function, and an increased risk of gastrointestinal adverse events Details Lumiracoxib Aspirin Rectal Aspirin An increased risk of bleeding, decreased renal function, and an increased risk of gastrointestinal adverse events Details Lumiracoxib Betrixaban Bevyxxa® An increased risk of bleeding Details Lumiracoxib Anagrelide Agrylin An increased risk of bleeding Details Lumiracoxib Bromfenac Ophthalmic Bromday® Increased risk of bleeding Details Lumiracoxib Budesonide Entocort Increased risk of gastrointestinal ulcer or bleeding Details Lumiracoxib Budesonide Nasal Spray Rhinocort Increased risk of gastrointestinal ulcer or bleeding Details Lumiracoxib Budesonide Oral Inhalation Pulmicort Increased risk of gastrointestinal ulcer or bleeding Details Lumiracoxib Clopidogrel Plavix An increased risk of bleeding Details Lumiracoxib Cyclosporine Injection Atopica An increased risk of cycloSPORINE nephrotoxicity Details Lumiracoxib Cyclosporine Ophthalmic Cequa An increased risk of cycloSPORINE nephrotoxicity Details Lumiracoxib Dabigatran Pradaxa® An increased risk of bleeding Details Lumiracoxib Dabigatran Etexilate An increased risk of bleeding Details Lumiracoxib Dalteparin Injection Fragmin An increased risk of bleeding Details Lumiracoxib Deflazacort Emflaza Increased risk of gastrointestinal ulcer or bleeding Details Lumiracoxib Dexamethasone Injection Decadron Increased risk of gastrointestinal ulcer or bleeding Details Lumiracoxib Dexamethasone Ophthalmic Dexacidin® (as a combination product containing Dexamethasone, Neomycin, Polymyxin B) Increased risk of gastrointestinal ulcer or bleeding Details Lumiracoxib Diclofenac Ophthalmic Voltaren® Eye Drops Increased risk of bleeding Details Lumiracoxib Diclofenac Topical (Actinic Keratosis) Pennsaid Increased risk of bleeding Details Lumiracoxib Diclofenac Topical (Arthritis Pain) Pennsaid® Increased risk of bleeding Details Lumiracoxib Diclofenac Transdermal Patch Flector Increased risk of bleeding Details Lumiracoxib Digoxin Cardoxin® Increased digoxin exposure and prolonged half-life of digoxin Details Lumiracoxib Dipyridamole Permole® An increased risk of bleeding Details Lumiracoxib Edoxaban Savaysa An increased risk of bleeding Details Lumiracoxib Emtricitabine Emtriva Increased emtricitabine exposure and an increased risk of emtricitabine-related adverse effects Details Lumiracoxib Enoxaparin Lovenox An increased risk of bleeding Details Lumiracoxib Enoxaparin Injection Lovenox An increased risk of bleeding Details Lumiracoxib Epoprostenol Flolan An increased risk of bleeding Details Lumiracoxib Etodolac Lodine Increased risk of bleeding Details Lumiracoxib Fenoprofen Fenopron Increased risk of bleeding Details Lumiracoxib Flurbiprofen Ansaid Increased risk of bleeding Details Lumiracoxib Flurbiprofen Ophthalmic Ocufen Increased risk of bleeding Details Lumiracoxib Fondaparinux Arixtra An increased risk of bleeding Details